Posts in tag
immune disease
Inflectra to be PBS listed from December
Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.
Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.
All content on AJP.com.au is restricted to registered users only.
To continue enjoying access to all the news, views, information and education you’ve come to trust, please login & stay in.
And if you don’t already have a login – register now!
